NCT01553786 Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL) Status COMPLETED Phase PHASE2
NCT00959686 Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma Status COMPLETED Phase PHASE2
NCT00893516 CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma Status TERMINATED Phase PHASE2
NCT00322985 A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00161590 Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT00001582 Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer Status COMPLETED Phase N/A